Sign up
Quantellect · Congress · Trade Detail
NYSE: PFEPfizer Inc
RepublicanSenate

David Perdue sold Pfizer Inc (NYSE: PFE)

David Perdue (R-GA), a U.S. Senator, has disclosed 63 trades in Pfizer Inc (PFE) since 2015, 24 purchases and 39 sales, worth an estimated $892K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: David Perdue sold $1,001 - $15,000 of Pfizer Inc (NYSE: PFE) on October 30, 2018. Since that trade, PFE is down -11.32% against the S&P 500 up +205.52%, an outperformance of -216.84%.

Across these filings, David Perdue has been a net seller of PFE (a buy-to-sell ratio of 0.62). The most recent disclosed PFE transaction shown was dated April 14, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PFE trades
63
Disclosed Vol
$892K
Buys
24
38%
Sells
39
62%
Buy / Sell
0.62
ratio
First → Last
2015–2020

David Perdue's PFE trades vs the price

PFE is down -11.32% since David Perdue sold on October 30, 2018, versus +205.52% for the S&P 500.

Performance since this trade

Price change since trade
-11.32%
S&P 500 change since trade
+205.52%
Outperformance vs S&P 500
-216.84%

All David Perdue PFE trades

TradedTypeSizeReturnEst. profit
April 14, 2020SELL$25.44-1.14%
April 3, 2020SELL$23.48+7.09%
February 28, 2020BUY$23.33+7.79%-$8K
February 28, 2020BUY$23.33+7.79%-$2K
February 28, 2020BUY$23.33+7.79%-$8K
February 27, 2020BUY$23.81+5.65%-$9K
February 27, 2020BUY$23.81+5.65%-$2K
February 26, 2020BUY$24.24+3.76%-$2K
February 26, 2020BUY$24.24+3.76%-$9K
February 26, 2020BUY$24.24+3.76%-$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

David Perdue & PFE trading FAQ

Is it legal for David Perdue to trade Pfizer Inc (PFE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Pfizer Inc (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did David Perdue sell PFE?

David Perdue disclosed a sale of $1,001 - $15,000 of Pfizer Inc (PFE) on October 30, 2018, according to public STOCK Act filings.

How has PFE performed since David Perdue's trade?

Since David Perdue sold PFE on October 30, 2018, the stock is down -11.32%, versus +205.52% for the S&P 500 over the same period, an outperformance of -216.84%.

How many times has David Perdue traded PFE?

David Perdue has disclosed 63 PFE trades since 2015 (24 purchases and 39 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PFE trades?

Quantellect tracks every disclosed congressional trade in Pfizer Inc (PFE) on the Pfizer Inc congressional trading page, which aggregates filings across all members of Congress.

David Perdue's PFE tradesAll congressional filings for Pfizer IncDavid Perdue's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.